Sun Pharma
Sun Pharma makes strategic Russian firm acquisition
November 23, 2016Research and Development, Sales and Marketing Biosintez, Russia, Sun Pharma
Sun Pharmaceutical, India’s largest pharmaceutical company, has acquired Russian pharmaceutical company JSC Biosintez in a total deal of $60 million. …
Pfizer launches legal action to block Xeljanz copies in India
September 9, 2016Medical Communications, Sales and Marketing Pfizer, Sun Pharma, Xeljanz, Zydus Cadila, rheumatoid arthritis
Pfizer has pre-emptively sued a number of India-based drug companies including Sun Pharma and Zydus Cadila to block any attempts …
Sun Pharma to partner with ICGEB to develop novel Dengue treatment
May 4, 2016Research and Development Dengue fever, Sun Pharma, collaboration, dengue, development, drug, icgeb, international centre for genetic engineering and biotechnology, partnership, sun pharmaceutical
Sun Pharmaceuticals (BSE: 85715) and the International Centre for Genetic Engineering and Biotechnology (ICGEB) are set to team up to …
Sun Pharma receives FDA approval for ocular pain treatment
April 11, 2016Research and Development, Sales and Marketing FDA, Sun Pharma, bromsite, ocular treatment
Sun Pharma (BSE: 524715) has announced that their ocular pain prevention treatment, BromSite (bromfenac ophthalmic solution), has been approved by …
Sun to cut jobs in Irish facility closure; Lilly announce further investment in the country
April 6, 2016Manufacturing and Production, Research and Development Eli Lilly, Ireland, Kinsale, Sun Pharma, cashel, investment, lilly
There was mixed news for pharmaceutical manufacturing in Ireland as Sun Pharma announced its decision to close its facility based …
Sun Pharma forays into Japan with $293 million product buy from Novartis
March 30, 2016Manufacturing and Production, Research and Development, Sales and Marketing Japan, M&A, MA, Novartis, Sun Pharma, generics
Shares of Sun Pharma (BOM: 524715), the largest Indian drug maker rose over 2% Wednesday as the company announced the …
Sun Pharma agree deal to distribute AstraZeneca type-2 diabetes drug in India
March 24, 2016Sales and Marketing AstraZeneca, India, Sun Pharma, diabetes, oxra, type 2, type-2
Sun Pharma has agreed a deal with AstraZeneca to promote and distribute their type-2 diabetes drug, dapagliflozin, in India. Marketed …
Sun Pharma takes on Novartis in the US with generic Glivec
February 2, 2016Manufacturing and Production, Research and Development, Sales and Marketing Gleevec, Novartis, Sun Pharma
Mumbai-based drug manufacturer Sun Pharma has launched a generic version of Glivec, for the same indications for which the former …
Sun Pharma hit by FDA inspection warning
December 22, 2015Manufacturing and Production FDA, Sun Pharma, manufacturing, production
Sun Pharma shares fell some 7% early this week after it emerged the Indian company received a warning letter from …
FDA warnings create woe for Indian drugmakers
November 10, 2015Manufacturing and Production CGMP, Dr Reddy's, Dr. Reddy's, FDA, India, Sun Pharma, manufacturing, production
Recent enforcement action has taken its toll on the fortunes of several Indian pharmaceutical manufacturers, with Sun Pharmaceuticals and Dr. …
FDA withdraws approval for Sun Pharma’s epilepsy drug
September 29, 2015Manufacturing and Production Elepsia, FDA, Sun Pharma, epilepsy, levetiracetam, manufacturing, productions, seizures
Manufacturing problems at Sun Pharma’s production site has led the FDA to revoke the company’s approval for Elepsia XR for …
Sun Pharma strengthens opiates business
September 8, 2015Manufacturing and Production Australia, GSK, Sun Pharma, manufacturing and production, opiates
Sun Pharmaceutical Industries has strengthened its global opiates manufacturing business with the acquisition of two Australian manufacturing facilities from GlaxoSmithKline. …
Sun Pharma sacks 18 Ranbaxy executives
June 19, 2015Manufacturing and Production, Sales and Marketing Daiichi, India, Ranbaxy, Sun Pharma, brett wells
Sun Pharma has asked 18 executives to leave the company who were previously a part of Ranbaxy, the firm it …
Daiichi Sankyo to sell Sun Pharma stake
April 21, 2015Manufacturing and Production, Sales and Marketing Daiichi Sankyo, FDA, India, Ranbaxy, Sun Pharma, generics
Daiichi Sankyo is to sell off all or part of its stake in Sun Pharma and back away from the …
Sun Pharma and Technion form oncology research pact
April 16, 2015Research and Development, Sales and Marketing Cancer, Sun Pharma, institute of technology, oncology, technion
Mumbai-based Sun Pharmaceuticals Industries is teaming up with the Israel Institute of Technology Technion to develop new oncology drugs. This …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
